ND0612H
Phase 2- Indications
- Severe Parkinson's disease
Company intelligence / Profile preview
GI‑View develops single-use endoscopic devices for gastrointestinal procedures. Its flagship product, the Aer-O-Scope disposable colonoscope, has received FDA 510(k) clearance and offers a panoramic field of view to improve polyp detection during colorectal cancer screening. The system aims to reduce infection risk by eliminating cross-contamination between patients and lowering maintenance costs. The Aer-O-Scope system features a joystick-controlled, self-propelled design with therapeutic access channels for interventions such as biopsy or polyp removal. Other single-use scopes are in development.
4 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GI-View.